Niloufar Khamnehei is an expert in the field of Internal Medicine. Niloufar Khamnehei, MD has written publications. She has 1 publication published with PubMed. The lastest publication is: 'Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.' Dr. Niloufar Khamnehei is registered with Medicare.
NPI NUMBER | 1134197585 | |
NPPES Provider LastName | KHAMNEHEI | |
NPPES Provider FirstName | NILOUFAR | |
NPPES Provider ZIPCode | 940103205 | |
NPPES Provider State | CA | |
Specialty Description | Internal Medicine | |
Total Claim Count | 107.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1134197585 |
Last Name Of The Provider | KHAMNEHEI |
First Name Of The Provider | NILOUFAR |
View All |
![]() |
Dr. Lai L. Aung, MD
![]() |
![]() |
Dr. Jerrold M. Kaplan, MD |
![]() |
Dr. Simon K. Lee, MD
![]() |
![]() |
Dr. Nani Khananashvili, MD
![]() |
![]() |
Dr. Abhijit A. Adhye, MD
![]() |
![]() |
Dr. Edward V. Abratowski, MD
![]() |
![]() |
Dr. Dolores E. Ali, MD
![]() |
![]() |
Dr. Donald A. Calvo, MD |
![]() |
Dr. Yannick M. Leguyader, MD |